Global EditionASIA 中文双语Français
Business
Home / Business / Companies

Two sessions: top entrepreneurs share ideas

chinadaily.com.cn | Updated: 2021-03-09 06:40
Share
Share - WeChat

Li Yan, president of Qilu Pharmaceuticals

Li Yan, president of Qilu Pharmaceuticals and a deputy to the 13th National People's Congress. [Photo/Qilu Pharmaceuticals]

The bioengineering and pharmaceutical industry in China is still in a catch-up phase, facing many barriers to break through, said Li Yan.

She suggested top-level design for the industry should be enhanced, where high-level policies supporting the development of the bioengineering and pharmaceutical industries should be rolled out as soon as possible, getting through every linkages including new drug project approval, reviewing, production and application. New research and development for global cutting-edge products should be encouraged. Industrial and supply chains of the industries should be strengthened in terms of stability and competitiveness.

|<< Previous 1 2 3 4 5 6 7 8 9   
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE